Researchers theorize this may be because: GIP activation may counterbalance some GLP-1 effects on the gut Dose escalation schedule allows more gradual adaptation Different pharmacokinetic profile may produce less pronounced peaks Serious Side Effects (Both Medications): These are rare but require immediate medical attention: Pancreatitis: Severe abdominal pain that may radiate to the back Risk: Less than 1% with both medications Usually occurs in first few months of treatment Requires immediate discontinuation if suspected Gallbladder Problems: Gallstones, cholecystitis (gallbladder inflammation) Symptoms: Right upper abdominal pain, nausea, fever More common with rapid weight loss May require surgical intervention Kidney Problems: Dehydration from vomiting/diarrhea can affect kidney function Watch for decreased urination, swelling in legs Stay well-hydrated, especially during side effect periods Thyroid Tumors (Black Box Warning): Both medications carry warnings about thyroid C-cell tumors Based on rodent studies

Empty stomach morning for increased fat burning potential
Theo mt nghin cu t H Helsinki, b sung vitamin C c th gim 50% t l b cm lnh nhng ngi thng xuyn vn ng ngoi tri
Not only does ketamine exert rapid-acting antidepressant effects in animals and humans, but its IV administration is associated with normalization of spine, synapse, dendrite, and prefrontal cortical communication deficits within a few hours
What is real cause of diahrea
Potential of GLP-1 drugs to treat diseases beyond obesity explored A paper published today in the journal Science explores the potential of glucagon-like peptide-1 (GLP-1)-based drugs such as semaglutide to treat diseases beyond diabetes and obesity